{"result": {"id": "34aa67b9-591c-4d1b-a394-db4be19aa8d9", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CCB<|>ORGANIZATION<|>CCB refers to Calcium Channel Blockers, a class of drugs that enhance the effects of various anesthetic and analgesic medications during surgery\")  \n##  \n(\"entity\"<|>ACEI<|>ORGANIZATION<|>ACEI stands for Angiotensin-Converting Enzyme Inhibitors, a type of medication that can cause intraoperative hypotension and is recommended to be discontinued one day before surgery\")  \n##  \n(\"entity\"<|>ARB<|>ORGANIZATION<|>ARB stands for Angiotensin Receptor Blockers, another class of antihypertensive drugs that may lead to low blood pressure during surgery and should be stopped before the procedure\")  \n##  \n(\"entity\"<|>ARNI<|>ORGANIZATION<|>ARNI stands for Angiotensin Receptor-Neprilysin Inhibitors, a combination drug that can contribute to intraoperative hypotension and is advised to be paused before surgery\")  \n##  \n(\"entity\"<|>SSRI<|>ORGANIZATION<|>SSRI stands for Selective Serotonin Reuptake Inhibitors, a type of antidepressant that may increase bleeding risk and is used to manage anxiety and depression in hypertensive patients\")  \n##  \n(\"entity\"<|>SNRI<|>ORGANIZATION<|>SNRI stands for Serotonin-Norepinephrine Reuptake Inhibitors, a class of antidepressants that can elevate blood pressure and is prescribed for hypertension patients with anxiety or depression\")  \n##  \n(\"relationship\"<|>CCB<|>ACEI<|>Both CCB and ACEI are classes of antihypertensive drugs that interact with anesthesia during surgery<|>6\")  \n##  \n(\"relationship\"<|>ARB<|>ARNI<|>ARB and ARNI are both antihypertensive medications that can cause intraoperative hypotension and are recommended to be discontinued before surgery<|>7\")  \n##  \n(\"relationship\"<|>SSRI<|>SNRI<|>SSRI and SNRI are both antidepressants used to treat anxiety and depression in hypertensive patients, but they carry different risks (bleeding vs. blood pressure elevation)<|>5\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558753, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 468, "prompt_tokens": 2490, "total_tokens": 2958, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 698}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 期手术 ,建议推迟手术 ;对于高血压合并其他  严重疾病 ,如高血压伴急性肾衰竭、严重低钾血症(<  2.9 mmol/L)等 ,应在短时间内采取措施改善靶器官  功能和纠正内环境紊乱 ,纠正后再施手术。\n　　　血压控制目标为<140/90mmHg。术中血压波 动幅度不超过基础血压的 30%[662]  。术中因高血压急 症静脉使用降压药的目标 :30~60min内使舒张压降 至 110mmHg,降压幅度不超过 25% ,2~ 6 h 内血压 降至 160/100mmHg。术中收缩压 <100mmHg和 平均动脉压 <60mmHg在非心脏手术中都是有害 的[663] 。 因 此 , 建 议 术 中 平 均 动 脉 压 应 保 持 在 > 65mmHg,术后稍微高一些[664] 。\n　8.13.3  药物治疗   治疗剂量的 CCB通常能增强静  脉麻醉药物、吸入麻醉药物、肌松药物和镇痛药物的作  用 ,可继续应用 。对术前服用 ACEI或 ARB或 ARNI 患者 , 因 易 引 起 术 中 低 血 压 , 建 议 术 前 1 d 予 以 停  用[662] 。术前要避免突然停用 β受体阻滞剂 ,防止心率  反跳 , 用至手术当日清晨[660]  。对正在使用利尿剂者  术前 2~3 d停用。\n8.14  心理障碍与高血压\n　8.14.1  抗焦虑、抑郁药物治疗    焦虑抑郁情绪和高  血压的发生、血压控制不良和治疗依从性差密切相  关[665-666] 。有研究显示 ,合并焦虑抑郁的高血压患者 ,  使用抗抑郁药及抗焦虑药有助于减少降压药的使用数  量和剂量 ,提高血压达标率[204] 。根据《精神障碍诊疗  规范(2020年版)》建议 , 推荐(1) 抗抑郁药 : 5-羟色胺  再摄 取 抑 制 剂 ( selective serotonin reuptake inhibi- tors,SSRI) 和 5-羟色胺和去甲肾上腺素再摄取抑制剂  (serotonin-norepinephrinereuptakeinhibitors,SNRI)  类抗抑郁药是最常用的药物 。 (2)抗焦虑药 :常用的抗  焦 虑 药 包 括 苯 二 氮  类 和  5-羟 色 胺   1A ( 5- hydroxytryptamine1A, 5-HT1A) 受 体 部 分 激 动 剂。 苯二氮类抗焦虑作用起效快 , 常在发作初期使用 ,  5-HT1A受体部分激动剂通常起效较慢 。如使用上述  药物无法有效改善焦虑抑郁症状 ,建议转诊到精神心  理专科医生治疗 。关注 SSRI类药物增加出血风险、 SNRI类药物升高血压的风险 。 由于抗抑郁药与降压\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_9a8988fdbc7d1c9e50233c6d239e94b373faacfad14e3c574c097942ecaecf0c_v2"}